PMID- 23433799 OWN - NLM STAT- MEDLINE DCOM- 20130611 LR - 20181202 IS - 1879-355X (Electronic) IS - 0360-3016 (Linking) VI - 86 IP - 1 DP - 2013 May 1 TI - A population-based study of the fractionation of postlumpectomy breast radiation therapy. PG - 51-7 LID - S0360-3016(12)03911-9 [pii] LID - 10.1016/j.ijrobp.2012.12.015 [doi] AB - PURPOSE: The optimal fractionation schedule of post lumpectomy radiation therapy remains controversial. The objective of this study was to describe the fractionation of post-lumpectomy radiation therapy (RT) in Ontario, before and after the seminal Ontario Clinical Oncology Group (OCOG) trial, which showed the equivalence of 16- and 25-fraction schedules. METHODS AND MATERIALS: This was a retrospective cohort study conducted by linking electronic treatment records to a population-based cancer registry. The study population included all patients who underwent lumpectomy for invasive breast cancer in Ontario, Canada, between 1984 and 2008. RESULTS: Over the study period, 41,747 breast cancer patients received post lumpectomy radiation therapy to the breast only. Both 16- and 25-fraction schedules were commonly used throughout the study period. In the early 1980s, shorter fractionation schedules were used in >80% of cases. Between 1985 and 1995, the proportion of patients treated with shorter fractionation decreased to 48%. After completion of the OCOG trial, shorter fractionation schemes were once again widely adopted across Ontario, and are currently used in about 71% of cases; however, large intercenter variations in fractionation persisted. CONCLUSIONS: The use of shorter schedules of post lumpectomy RT in Ontario increased after completion of the OCOG trial, but the trial had a less normative effect on practice than expected. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Ashworth, Allison AU - Ashworth A AD - Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada. FAU - Kong, Weidong AU - Kong W FAU - Whelan, Timothy AU - Whelan T FAU - Mackillop, William J AU - Mackillop WJ LA - eng PT - Journal Article DEP - 20130220 PL - United States TA - Int J Radiat Oncol Biol Phys JT - International journal of radiation oncology, biology, physics JID - 7603616 SB - IM CIN - Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):632-3. PMID: 24138908 CIN - Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):633. PMID: 24138910 MH - Adult MH - Aged MH - Aged, 80 and over MH - Breast Neoplasms/epidemiology/*radiotherapy/surgery MH - *Dose Fractionation, Radiation MH - Female MH - Health Services Accessibility/statistics & numerical data MH - Humans MH - *Mastectomy, Segmental/statistics & numerical data MH - *Medical Record Linkage MH - Middle Aged MH - Ontario/epidemiology MH - Postoperative Care/statistics & numerical data MH - Radiotherapy, Adjuvant/statistics & numerical data MH - Randomized Controlled Trials as Topic MH - *Registries MH - Regression Analysis MH - Retrospective Studies EDAT- 2013/02/26 06:00 MHDA- 2013/06/12 06:00 CRDT- 2013/02/26 06:00 PHST- 2012/07/31 00:00 [received] PHST- 2012/11/23 00:00 [revised] PHST- 2012/12/18 00:00 [accepted] PHST- 2013/02/26 06:00 [entrez] PHST- 2013/02/26 06:00 [pubmed] PHST- 2013/06/12 06:00 [medline] AID - S0360-3016(12)03911-9 [pii] AID - 10.1016/j.ijrobp.2012.12.015 [doi] PST - ppublish SO - Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):51-7. doi: 10.1016/j.ijrobp.2012.12.015. Epub 2013 Feb 20.